Iron in parkinsonian and control substantia nigra - A Mössbauer spectroscopy study

Movement Disorders

Volumn 11, Issue 1, 1996, Pages 8-16

  Galazka Friedman J ^a   Bauminger, E R ^b   Friedman, A ^c   Barcikowska, M ^d   Hechel, D ^b   Nowik, I ^b  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Iron; M ssbauer spectroscopy; Parkinson's disease; Substantia nigra

Indexed keywords

FERRIC ION; FERRITIN; FERROUS ION; FORMALDEHYDE; IRON;

ADULT; AGED; ARTICLE; BINDING SITE; CONTROLLED STUDY; FREEZE DRYING; FROZEN SECTION; HUMAN; HUMAN TISSUE; MOSSBAUER SPECTROSCOPY; OXIDATION REDUCTION STATE; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; FEMALE; FERRIC COMPOUNDS; FERRITINS; FERROUS COMPOUNDS; HUMANS; IRON; MALE; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; SPECTROSCOPY, MOSSBAUER; SUBSTANTIA NIGRA;

EID: 0029671110     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110104     Document Type: Article

References (40)

1. Halliwell B. Oxidants and the central nervous system: some fundamental questions. Acta Neurol Scand 1989;126:23-33.
2. Youdim MBH, Ben-Shachar D, Riederer P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 1989;126:47-54.
3. Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidences supporting it. Ann Neurol 1992;32: 804-812.
4. Calne DB. The free radical hypothesis in idiopathic parkinsonism: evidence against it. Ann Neurol 1992;32:799-803.
5. Earle KM. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 1968;27:1-14.
6. Sofic E, Riederer P, Heinsen H, et al. Increased iron (III) and total iron content in post-mortem substantia nigra of parkinsonian brain. J Neural Transm 1988;74:199-205.
7. Riederer P, Sofic E, Rausch WD, et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 1989;52:515-520.
8. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 1989;52:1830-1836.
9. Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in post mortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 1993;4:61-65.
10. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MBH. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect 1990;2: 327-340.
11. Mann VM, Cooper JM, Daniel SE, et al. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994;36:876-881.
12. Uitti RJ, Rajput AH, Rozdilsky B, Bickis M, Wollin T, Yuen WK. Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains. Can J Neurol Sci 1989;16:310-314.
13. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJNR Am J Neuroradiol 1987;8:397-411.
14. 2 relaxation time in patients with Parkinson's disease. Neurology 1993;43:697-700.
15. Hallgren B, Sourander P. The effect of age on non-haemin iron in human brains. J Neurochem 1958;3:41-51.
16. Halliwell B, Gutteridge JMC. Iron and free radical reactions: two aspects of antioxidant protection. Trends Biol Sci 1986; 11:1372-1375.
17. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-1975.
18. Jellinger K, Kienzl E, Rumpelmair G, et al. Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis. J Neurochem 1992;59:1168-1171.
19. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an x-ray microanalysis. J Neurochem 1991;56:446-451.
20. Good PF, Olanow CW, Perl DP. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminium in Parkinson's disease: a LAMMA study. Brain Res 1992;593:343-346.
21. Bauminger ER, Barcikowska M, Friedman A, Gała̧zka-Friedman J, Hechel D, Nowik I. Does iron play a role in Parkinson's disease? Hyperfine Interactions 1994;91:853-857.
22. Greenwood NN, Gibb TC. Mössbauer spectroscopy. London: Chapman & Hall, 1971:112-168.
23. Bauminger ER, Cohen SG, Ofer S, Rachmilevitz AE. Quantitative studies of ferritin-like iron in erythrocytes of thalassemia, sickle cell anemia and hemoglobin Hammersmith with Mössbauer spectroscopy. Proc Natl Acad Sci USA 1979;76:939-943.
24. Bauminger ER, Harrison PM, Nowik I, Treffry A. Mössbauer spectroscopy study of the initial stages of iron-core formation in horse spleen apoferritin: evidence for both isolated Fe (III) atoms and oxo-bridged dimers as early intermediates. Biochemistry 1989;28:5486-5493.
25. Bauminger ER, Harrison PM, Hechel D, Nowik I, Treffry A. Mössbauer spectroscopic investigation of structure-function relations in ferritins. Biochim Biophys Acta 1991;1118: 48-58.
26. Watt GD, Frankel RB, Papaefthymiou GC. Reduction of mammalian ferritin. Proc Natl Acad Sci USA 1985;82:3640-3643.
27. König I, Hollatz R. A fingerprint technique using Mössbauer spectroscopy for the determination of individual chemical iron species in young sediments. Hyperfine Interactions 1990;57:2245-2250.
28. Koller WC. How accurately can Parkinson's disease be diagnosed? Neurology 1992;42(suppl 1):6-16.
29. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
30. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42: 1142-1146.
31. Cohen RL. Improvements of electromagnetic velocity drive for Mössbauer experiments. Rev Sci Instrum 1966;37:957-959.
32. Blume M, Tjon JA. Mössbauer spectra in a fluctuating environment. Phys Rev 1968;165:446-456.
33. Frauenfelder H. The Mossbauer effect. New York: WA Benjamin, 1962:48.
34. Bell SH, Weir MP, Dickson DPE, Gibson JF, Sharp GA, Peters TJ. Mössbauer spectroscopic studies of human haemosiderin and ferritin. Biochim Biophys Acta 1984;787:227-236.
35. Bardani L, Bridelli MG, Carbucicchio M, Crippa PR. Comparative Mössbauer and infrared analysis of iron-containing melanins. Biochim Biophys Acta 1982;716:8-15.
36. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood 1977;50:433-439.
37. Ambe S. Mössbauer study of iron in soybean hulls and cotyledons. J Agric Food Chem 1994;42:262-267.
38. Zecca L, Swartz HM. Total and paramagnetic metals in human substantia nigra and its neuromelanin. J Neural Transm Park Dis Dement Sect 1993;5:203-213.
39. Youdim MBH, Ben-Shachar D, Riederer P. The possible role of iron in etiopathology of Parkinson's disease. Mov Disord 1993;8:1-12.
40. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 1994;63:793-807.